drugset / Trial / NCT00348400

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

NCT00348400 ↗

Phase 4 Completed Innovative Medical
RandomizedParallel-groupSingle-blind

Summary

Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Unknown 0.15 % —
Subject Dorzolamide Small molecule 2 % —
Background Latanoprost Small molecule — —

Indications